アジア太平洋の経皮ドラッグデリバリーシステム：2030年市場予測-地域別分析-タイプ別、用途別、流通チャネル別

アジア太平洋の経皮ドラッグデリバリーシステム市場は、2022年の90億2,989万米ドルから2030年には128億2,077万米ドルに成長すると予測されています。2022～2030年のCAGRは4.5%と推定されます。

スマートパッチと3Dプリントパッチの進歩がアジア太平洋の経皮ドラッグデリバリーシステム市場に拍車をかける

経皮薬剤投与ルートは新規性があり、持続的ドラッグデリバリーの信頼できる手段の一つです。このセグメントで重要な研究が行われ、この形態のドラッグデリバリーに対する研究者の関心が高まっていることから、今後、多くの経皮パッチが市場に登場すると考えられます。経皮パッチは、ニコチン、フェンタニル、ニトログリセリン、クロニジンなどの薬剤を送達し、さまざまな病状を治療するために使用されます。最近では、これらのパッチは、様々な用途で生物製剤を送達するために研究されています。スマートパッチは、患者の状態をモニターし、それに応じてドラッグデリバリーを調整するためのセンサーやその他の技術を備えています。2023年1月、Swansea Universityの主任科学者は、マイクロニードル技術を用いてパーキンソン病やアルツハイマー病などの神経変性疾患の炎症性バイオマーカーを検出する新しいスマートパッチを開発しました。このスマートパッチは、低侵襲で皮膚バリアを貫通するように設計された多数のマイクロニードルで構成され、その後、臨床的に重要なバイオマーカーをモニタリングします。一般クリニックや自宅でのポイントオブケア診断のために自己投与が可能です。この革新的な調査によって、神経変性疾患の早期発見が大きく変わる可能性があります。

皮膚外用3Dプリント製品：2021年11月にNational Library of Medicineに掲載された「From Personalized Dressings to Drug Delivery」によると、皮膚表面に適合するパーソナライズされた3Dプリントパッチは、アセチルヘキサペプチド3（AHP-3）のデリバリーに使用できます。この研究では、ポリエチレングリコールジアクリレート（PEGDA）とビニルピロリドン（VP）という2種類の液体モノマーを異なる割合で使用し、最終ポリマーの機械的強度、重合速度、膨潤速度を改善しました。樹脂への最適な薬剤担持により、AHP-3は製造工程を通して安定であり、最終ポリマーの物性に影響を及ぼさないことが示されました。3Dスキャンされた顔面モデルを用いて、パーソナライズされたパッチがコンピュータ支援設計ソフトウェアで設計され、デジタル光加工3Dプリンタを用いて最適化された樹脂で作製されました。調製された経皮パッチのin-vitro特性評価により、ヒトの死体皮膚に浸透する能力が示され、さらに圧縮しても無傷のままであることが確認されました。

このように、3Dプリンティング技術とスマートパッチの採用は、今後数年間、経皮ドラッグデリバリーシステム市場に機会を提供する可能性が高いです。

アジア太平洋の経皮ドラッグデリバリーシステム市場概要

アジア太平洋の経皮ドラッグデリバリーシステム市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。高齢化人口の増加、心血管疾患の有病率の増加、非侵襲的医療機器に対する需要の増加により、中国、インド、オーストラリアなどの国々で市場の急成長が見込まれています。アジア太平洋では、中国が経皮ドラッグデリバリーシステムの最大市場です。中国における経皮ドラッグデリバリーシステム市場の成長は、主に同国における技術の成長、疼痛管理用の経皮パッチや半固形製品を開発する市場参入企業の増加によるものです。

また、ここ数年、中国企業は経皮ドラッグデリバリーシステム業界における事業拡大のため、製品の上市や承認、買収、提携、合併を行っています。例えば、2022年1月にSuzhou Reveda Medical Co., Ltd. (REVEDA)は、Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical)とドラッグデバイスコンビネーション製品の合弁会社を設立し、経皮デリバリー用ポリペプチドマイクロニードルセグメントで提携すると発表しました。合弁会社の60%はREVEDA Medicalが、40%はHybio Pharmaceuticalが所有します。さらに、2021年9月、英国の医薬品・医療製品規制庁は、アルツハイマー病に伴う軽度から中等度の認知症の治療として、Luye Pharma Groupの革新的な製剤であるリバスチグミン経皮吸収型パッチ（Rivastigmine Multi-Day Transdermal Patch：リバスチグミンMD）の販売承認を承認しました。すでに欧州連合（EU）加盟国の数カ国が同剤の販売承認を取得しています。このように、上記の要因から、この国の経皮吸収型ドラッグデリバリーシステム市場は、今後数年間で需要を押し上げると予想されます。

アジア太平洋の経皮ドラッグデリバリーシステム市場の収益と2030年までの予測（金額）

アジア太平洋の経皮ドラッグデリバリーシステム市場セグメンテーション

アジア太平洋の経皮ドラッグデリバリーシステム市場は、タイプ、用途、流通チャネル、国に区分されます。

タイプ別では、アジア太平洋の経皮ドラッグデリバリーシステム市場は、経皮パッチ、経皮ゲル、経皮スプレー、その他に区分されます。2022年のアジア太平洋の経皮ドラッグデリバリーシステム市場では、経皮ゲルセグメントが最大のシェアを占めています。経皮パッチはさらに、薬剤接着パッチ、マトリックスパッチ、リザーバー膜パッチ、蒸気パッチに細分化されます。

用途別では、アジア太平洋の経皮ドラッグデリバリーシステム市場は、心血管疾患、中枢神経障害、疼痛管理、ホルモン用途、その他の用途に分類されます。疼痛管理セグメントは、2022年のアジア太平洋の経皮ドラッグデリバリーシステム市場で最大のシェアを占めました。疼痛管理はさらにオピオイドと非オピオイドにサブセグメント化されます。ホルモン用途はさらに、経皮エストロゲン＆プロゲステロン療法とテストステロン補充に細分化されます。

流通チャネル別では、アジア太平洋の経皮ドラッグデリバリーシステム市場は病院薬局、小売薬局、オンライン薬局、その他に区分されます。2022年のアジア太平洋の経皮ドラッグデリバリーシステム市場では、病院薬局セグメントが最大のシェアを占めています。

国別に見ると、アジア太平洋の経皮ドラッグデリバリーシステム市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に分類されます。2022年のアジア太平洋の経皮ドラッグデリバリーシステム市場は中国が独占しています。

Boehringer Ingelheim International GmbH、GSK Plc、Hisamitsu Pharmaceutical Co Inc、Johnson & Johnson、Luye Pharma Group Ltd、Novartis AG、Viatris Incは、アジア太平洋の経皮ドラッグデリバリーシステム市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

• 主要な洞察

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 アジア太平洋の経皮ドラッグデリバリーシステム市場-主要産業力学

• 市場促進要因
  • 慢性疾患の有病率の増加
  • 非侵襲ドラッグデリバリーデバイスへの需要の高まり
  • 薬剤の自己投与に対する高い需要
• 市場抑制要因
  • 経皮ドラッグデリバリーシステムの副作用とリコール
• 市場機会
  • スマートパッチと3Dプリントパッチの進歩
• 今後の動向
  • メーカーによる戦略的取り組み
• 影響分析

第5章 経皮ドラッグデリバリーシステム市場：アジア太平洋市場分析

• アジア太平洋の経皮ドラッグデリバリーシステム市場収益、2022～2030年

第6章 アジア太平洋の経皮ドラッグデリバリーシステム市場：タイプ別収益と2030年までの予測

• イントロダクション
• アジア太平洋の経皮ドラッグデリバリーシステム市場2022年・2030年タイプ別売上高シェア（%）
• 経皮パッチ
• 経皮ゲル
• 経皮スプレー
• その他

第7章 アジア太平洋の経皮ドラッグデリバリーシステム市場：用途別収益と2030年までの予測

• イントロダクション
• アジア太平洋の経皮ドラッグデリバリーシステム市場：2022年と2030年の用途別売上高シェア（%）
• 心血管疾患
• 中枢神経系疾患
• 疼痛管理
• ホルモン用途
• その他

第8章 アジア太平洋の経皮ドラッグデリバリーシステム市場：2030年までの収益と予測：流通チャネル別

• イントロダクション
• アジア太平洋の経皮ドラッグデリバリーシステム市場：2022年と2030年の流通チャネル別売上高シェア（%）
• 病院薬局
• 小売薬局
• オンライン薬局
• その他

第9章 アジア太平洋の経皮ドラッグデリバリーシステム市場：2030年までの収益と予測：国別分析

• 中国
• 日本
• インド
• オーストラリア
• 韓国
• その他のアジア太平洋

第10章 経皮ドラッグデリバリーシステム市場業界情勢

• イントロダクション
• 経皮ドラッグデリバリーシステム市場の成長戦略
• 無機的成長戦略
• 有機的成長戦略

第11章 企業プロファイル

• Novartis AG
• Johnson & Johnson
• GSK Plc
• Viatris Inc
• Boehringer Ingelheim International GmbH
• Hisamitsu Pharmaceutical Co Inc
• Luye Pharma Group Ltd

第12章 付録

List Of Tables

• Table 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation
• Table 2. China: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 3. China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 4. China: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 5. China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 6. China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 7. China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
• Table 8. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 9. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 10. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 11. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 12. Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 13. Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
• Table 14. India: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 15. India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 16. India: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 17. India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 18. India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 19. India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
• Table 20. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 21. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 22. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 23. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 24. Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 25. Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
• Table 26. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 27. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 28. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 29. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 30. South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 31. South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
• Table 32. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 33. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 34. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 35. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
• Table 37. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
• Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
• Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
• Table 40. Glossary of Terms, Asia Pacific Transdermal Drug Delivery System Market

List Of Figures

• Figure 1. Asia Pacific Transdermal Drug Delivery System Market Segmentation, By Country
• Figure 2. Asia Pacific Transdermal Drug Delivery System Market: Key Industry Dynamics
• Figure 3. Asia Pacific Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
• Figure 4. Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
• Figure 5. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
• Figure 6. Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 7. Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 8. Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 14. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
• Figure 15. Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 20. Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 23. Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
• Figure 25. Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 26. Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 27. Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 28. Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 29. Asia Pacific Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 30. Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
• Figure 31. China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 32. Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 33. India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 34. Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 35. South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 36. Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market

The Asia Pacific transdermal drug delivery system market is expected to grow from US$ 9,029.89 million in 2022 to US$ 12,820.77 million by 2030. It is estimated to register a CAGR of 4.5% from 2022 to 2030.

Advancements in Smart Patches and 3D-Printed Patches Fuel Asia Pacific Transdermal Drug Delivery System Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Asia Pacific Transdermal Drug Delivery System Market Overview

The Asia Pacific transdermal drug delivery systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is expected to be fastest in countries such as China, India, and Australia due to growing aging population, increasing prevalence of cardiovascular diseases, and increasing demand for non-invasive medical devices. In Asia Pacific, China is the largest market of transdermal drug delivery systems. The growth of the transdermal drug delivery system market in China is primarily attributed to the growing technology in the country, increasing developments by the market players to develop transdermal patches and semisolid products for pain management.

Also, in the last few years, companies in China are undergoing product launches and approvals, acquisitions, partnerships, and mergers to expand their business in the transdermal drug delivery systems industry. For instance, in January 2022, Suzhou Reveda Medical Co., Ltd. (REVEDA) announced that it partnered with Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical) to set up a joint venture for drug-device combination products and team up in the field of polypeptide micro-needles for transdermal delivery. 60% of the joint venture will be owned by REVEDA Medical and 40% by Hybio Pharmaceutical. Furthermore, in September 2021, the UK's Medicines and Healthcare Products Regulatory Agency granted marketing approval for Luye Pharma Group's innovative formulation Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) for the treatment of mild to moderate dementia associated with Alzheimer's disease. Several European Union nations already have marketing authorization for the medicine. Thus, owing to the abovementioned factors, the market is expected to propel the demand for transdermal drug delivery systems in this country in the upcoming years.

Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Transdermal Drug Delivery System Market Segmentation

The Asia Pacific transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022.

Based on country, the Asia Pacific transdermal drug delivery system market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc are some of the leading companies operating in the Asia Pacific transdermal drug delivery system market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Transdermal Drug Delivery System Market - Key Industry Dynamics

• 4.1 Market Drivers
  • 4.1.1 Increasing Prevalence of Chronic Diseases
  • 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
  • 4.1.3 High Demand for Self-Administration of Drugs
• 4.2 Market Restraints
  • 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
• 4.3 Market Opportunities
  • 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
• 4.4 Future Trends
  • 4.4.1 Strategic Initiatives by Manufacturers
• 4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

• 6.1 Overview
• 6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
• 6.3 Transdermal Patches
  • 6.3.1 Overview
  • 6.3.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.1 Drug-in-Adhesive Patches
      • 6.3.2.1.1 Overview
      • 6.3.2.1.2 Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.2 Matrix Patches
      • 6.3.2.2.1 Overview
      • 6.3.2.2.2 Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.3 Reservoir Membrane Patches
      • 6.3.2.3.1 Overview
      • 6.3.2.3.2 Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.4 Vapor Patches
      • 6.3.2.4.1 Overview
      • 6.3.2.4.2 Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Transdermal Gels
  • 6.4.1 Overview
  • 6.4.2 Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Transdermal Sprays
  • 6.5.1 Overview
  • 6.5.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 6.6 Others
  • 6.6.1 Overview
  • 6.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

• 7.1 Overview
• 7.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
• 7.3 Cardiovascular Diseases
  • 7.3.1 Overview
  • 7.3.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Central Nervous System Disorders
  • 7.4.1 Overview
  • 7.4.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Pain Management
  • 7.5.1 Overview
  • 7.5.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.2.1 Opioid
      • 7.5.2.1.1 Overview
      • 7.5.2.1.2 Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.2.2 Non-Opioid
      • 7.5.2.2.1 Overview
      • 7.5.2.2.2 Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Hormonal Applications
  • 7.6.1 Overview
  • 7.6.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
      • 7.6.2.1.1 Overview
      • 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.2.2 Testosterone Replacement
      • 7.6.2.2.1 Overview
      • 7.6.2.2.2 Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 7.7 Other Application
  • 7.7.1 Overview
  • 7.7.2 Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

• 8.1 Overview
• 8.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
• 8.3 Hospital Pharmacies
  • 8.3.1 Overview
  • 8.3.2 Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Retail Pharmacies
  • 8.4.1 Overview
  • 8.4.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Online Pharmacies
  • 8.5.1 Overview
  • 8.5.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

• 9.1 Asia Pacific Transdermal Drug Delivery System Market
  • 9.1.1 Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
    • 9.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.1.1 Overview
      • 9.1.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
      • 9.1.1.1.3.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
      • 9.1.1.1.4 China: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 9.1.1.1.4.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 9.1.1.1.4.2 China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
      • 9.1.1.1.5 China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 9.1.1.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.2.1 Overview
      • 9.1.1.2.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.2.3 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
      • 9.1.1.2.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
      • 9.1.1.2.4 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 9.1.1.2.4.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 9.1.1.2.4.2 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
      • 9.1.1.2.5 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 9.1.1.3 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.3.1 Overview
      • 9.1.1.3.2 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.3.3 India: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
      • 9.1.1.3.3.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
      • 9.1.1.3.4 India: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 9.1.1.3.4.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 9.1.1.3.4.2 India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
      • 9.1.1.3.5 India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 9.1.1.4 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.4.1 Overview
      • 9.1.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
      • 9.1.1.4.3.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
      • 9.1.1.4.4 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 9.1.1.4.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 9.1.1.4.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
      • 9.1.1.4.5 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 9.1.1.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.5.1 Overview
      • 9.1.1.5.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.5.3 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
      • 9.1.1.5.3.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
      • 9.1.1.5.4 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 9.1.1.5.4.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 9.1.1.5.4.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
      • 9.1.1.5.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 9.1.1.6 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.6.1 Overview
      • 9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
      • 9.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
      • 9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 9.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
      • 9.1.1.6.5 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

• 10.1 Overview
• 10.2 Growth Strategies in the Transdermal Drug Delivery System Market
• 10.3 Inorganic Growth Strategies
  • 10.3.1 Overview
• 10.4 Organic Growth Strategies
  • 10.4.1 Overview

11. Company Profiles

• 11.1 Novartis AG
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Johnson & Johnson
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 GSK Plc
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 Viatris Inc
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Boehringer Ingelheim International GmbH
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 Hisamitsu Pharmaceutical Co Inc
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Luye Pharma Group Ltd
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments

12. Appendix

• 12.1 About Us
• 12.2 Glossary of Terms